1. Weizmann Institute of Science, Israel

Abstract

Ceramides are a family of sphingophospholipids synthesized in the endoplasmic reticulum, which mediate cell stress responses, including apoptosis, autophagy and senescence, Serine palmitoyltransferase generates 3-ketosphinganine, which is reduced to dihydrosphingosine. N-Acylation allows the formation of dihydroceramides, which are subsequently reduced to form ceramides. Once synthesized, ceramides are trafficked from the ER to the Golgi bound to the ceramide transfer protein, CERT (COL4A3BP, Q9Y5P4). Ceramide can be metabolized via multiple routes, ensuring tight regulation of its cellular levels. Addition of phosphocholine generates sphingomyelin while carbohydrate is added to form glucosyl- or galactosylceramides. Ceramidase re-forms sphingosine or sphinganine from ceramide or dihydroceramide. Phosphorylation of ceramide generates ceramide phosphate. The determination of accurate kinetic parameters for many of the enzymes in the sphingolipid metabolic pathway is complicated by the lipophilic nature of the substrates.

Contents

GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a reference work which is most usefully represented as an on-line database. As in any publication this work should be appropriately cited, and the papers it cites should also be recognized. This document provides a citation for the relevant parts of the database, and also provides a reference list for the research cited by those parts. For further details see [4].

Please note that the database version for the citations given in GtoPdb are to the most recent preceding version in which the family or its subfamilies and targets were substantially changed. The links below are to the current version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb curators.

Database links

References

1. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J and Krönke M. (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937-47 [PMID:8808629]
2. Beauchamp E, Tekpli X, Marteil G, Lagadic-Gossmann D, Legrand P and Rioux V. (2009) N-Myristoylation targets dihydroceramide Delta4-desaturase 1 to mitochondria: partial involvement in the apoptotic effect of myristic acid. Biochimie 91: 1411-9 [PMID:19647031]
3. Bourque E, Celatka C, Hirth B, Metz M, Zhao Z, Skerlj R, Xiang Y, Jancisics K, Marshall J and Cheng S et al.. (2014) Glucosylceramide synthase inhibitors Patent number: WO2012129084A2.
4. Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL and Wu Y. (2020) Why data citation isn't working, and what to do about it Database 2020 [PMID:32367113]
5. Butters TD, van den Broek LAGM, Fleet GWJ, Krulle TM, Wormald MR, Dwek RA and Platt FM. (2000) Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis. Tetrahedron: Assymetry 11: 113-124
6. Camacho L, Simbari F, Garrido M, Abad JL, Casas J, Delgado A and Fabriàs G. (2012) 3-Deoxy-3,4-dehydro analogs of XM462. Preparation and activity on sphingolipid metabolism and cell fate. Bioorg Med Chem 20: 3173-9 [PMID:22537678]
7. Chan HM, Gu X-JJ, Huang Y, Li L, Mi Y, Qi W, Sendzik M, Sun Y, Wang L and Yu Z et al.. (2016) Triazolopyrimidine compounds and uses thereof Patent number: WO2016103155A1.
8. Chen Y and Cao Y. (2017) The sphingomyelin synthase family: proteins, diseases, and inhibitors. Biol Chem 398: 1319-1325 [PMID:28742512]
9. Cingolani F, Casasampere M, Sanllehí P, Casas J, Bujons J and Fabrias G. (2014) Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II. J Lipid Res 55: 1711-20 [PMID:24875537]
10. Coant N, Sakamoto W, Mao C and Hannun YA. (2017) Ceramidases, roles in sphingolipid metabolism and in health and disease. Adv Biol Regul 63: 122-131 [PMID:27771292]
11. Deng X, Lin F, Zhang Y, Li Y, Zhou L, Lou B, Li Y, Dong J, Ding T and Jiang X et al.. (2014) Identification of small molecule sphingomyelin synthase inhibitors. Eur J Med Chem 73: 1-7 [PMID:24374347]
12. Efremov IV, Kazmirski S, Li q, Thompson LA III, Wallace OW, Johnstone SD, Zhou F and Rahl P. (2020) MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Patent number: WO2020190754.
13. Fabrias G, Muñoz-Olaya J, Cingolani F, Signorelli P, Casas J, Gagliostro V and Ghidoni R. (2012) Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Prog Lipid Res 51: 82-94 [PMID:22200621]
14. Graf C, Klumpp M, Habig M, Rovina P, Billich A, Baumruker T, Oberhauser B and Bornancin F. (2008) Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor. Mol Pharmacol 74: 925-32 [PMID:18612076]
15. Han G, Gupta SD, Gable K, Niranjanakumari S, Moitra P, Eichler F, Brown Jr RH, Harmon JM and Dunn TM. (2009) Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci USA 106: 8186-91 [PMID:19416851]
16. He Y, Selvaraju S, Curtin ML, Jakob CG, Zhu H, Comess KM, Shaw B, The J, Lima-Fernandes E and Szewczyk MM et al.. (2017) The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex. Nat Chem Biol 13: 389-395 [PMID:28135237]
17. Hoch DG, Abegg D, Hannich JT, Pechalrieu D, Shuster A, Dwyer BG, Wang C, Zhang X, You Q and Riezman H et al.. (2020) Combined Omics Approach Identifies Gambogic Acid and Related Xanthones as Covalent Inhibitors of the Serine Palmitoyltransferase Complex. Cell Chem Biol 27: 586-597.e12 [PMID:32330443]
18. Houben E, Holleran WM, Yaginuma T, Mao C, Obeid LM, Rogiers V, Takagi Y, Elias PM and Uchida Y. (2006) Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis. J Lipid Res 47: 1063-70 [PMID:16477081]
19. Jiang X-C, Yeang C, Li Z, Chakraborty M, Zhang H and Fan Y.. (2009) Sphingomyelin biosynthesis: its impact on lipid metabolism and atherosclerosis. Clinical Lipidology 4: 595-609
20. Koch J, Gärtner S, Li CM, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman EH and Sandhoff K. (1996) Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease. J Biol Chem 271: 33110-5 [PMID:8955159]
21. Lahiri S and Futerman AH. (2005) LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem 280: 33735-8 [PMID:16100120]
22. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill Jr AH and Futerman AH. (2008) Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283: 5677-84 [PMID:18165233]
23. Li YL, Qi XY, Jiang H, Deng XD, Dong YP, Ding TB, Zhou L, Men P, Chu Y and Wang RX et al.. (2015) Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors. Bioorg Med Chem 23: 6173-84 [PMID:26314925]
24. Li Z, Fan Y, Liu J, Li Y, Huan C, Bui HH, Kuo MS, Park TS, Cao G and Jiang XC. (2012) Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 32: 1577-84 [PMID:22580896]
25. Li Z, Zhang H, Liu J, Liang CP, Li Y, Li Y, Teitelman G, Beyer T, Bui HH and Peake DA et al.. (2011) Reducing plasma membrane sphingomyelin increases insulin sensitivity. Mol Cell Biol 31: 4205-18 [PMID:21844222]
26. Liu J, Huan C, Chakraborty M, Zhang H, Lu D, Kuo MS, Cao G and Jiang XC. (2009) Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ Res 105: 295-303 [PMID:19590047]
27. Mao C, Xu R, Szulc ZM, Bielawska A, Galadari SH and Obeid LM. (2001) Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 276: 26577-88 [PMID:11356846]
28. Mao C, Xu R, Szulc ZM, Bielawski J, Becker KP, Bielawska A, Galadari SH, Hu W and Obeid LM. (2003) Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J Biol Chem 278: 31184-91 [PMID:12783875]
29. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T and Kawasaki T. (1995) Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun 211: 396-403 [PMID:7794249]
30. Mizutani Y, Kihara A and Igarashi Y. (2005) Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J 390: 263-71 [PMID:15823095]
31. Mlinar B and Corradetti R. (2003) Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons. Eur J Neurosci 18: 1559-71 [PMID:14511335]
32. Mo M, Yang J, Jiang XC, Cao Y, Fei J, Chen Y, Qi X, Chu Y, Zhou L and Ye D. (2018) Discovery of 4-Benzyloxybenzo[ d]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in db/ db Mice. J Med Chem 61: 8241-8254 [PMID:30074791]
33. Philipp S, Puchert M, Adam-Klages S, Tchikov V, Winoto-Morbach S, Mathieu S, Deerberg A, Kolker L, Marchesini N and Kabelitz D et al.. (2010) The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase. Proc Natl Acad Sci USA 107: 1112-7 [PMID:20080539]
34. Rabionet M, van der Spoel AC, Chuang CC, von Tümpling-Radosta B, Litjens M, Bouwmeester D, Hellbusch CC, Körner C, Wiegandt H and Gorgas K et al.. (2008) Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide synthase-3. J Biol Chem 283: 13357-69 [PMID:18308723]
35. Riebeling C, Allegood JC, Wang E, Merrill Jr AH and Futerman AH. (2003) Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 278: 43452-9 [PMID:12912983]
36. Sun W, Xu R, Hu W, Jin J, Crellin HA, Bielawski J, Szulc ZM, Thiers BH, Obeid LM and Mao C. (2008) Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. J Invest Dermatol 128: 389-97 [PMID:17713573]
37. Tani M, Iida H and Ito M. (2003) O-glycosylation of mucin-like domain retains the neutral ceramidase on the plasma membranes as a type II integral membrane protein. J Biol Chem 278: 10523-30 [PMID:12499379]
38. Tani M and Kuge O. (2009) Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes. Biochem Biophys Res Commun 381: 328-32 [PMID:19233134]
39. Venkataraman K, Riebeling C, Bodennec J, Riezman H, Allegood JC, Sullards MC, Merrill Jr AH and Futerman AH. (2002) Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J Biol Chem 277: 35642-9 [PMID:12105227]
40. Wang K, Xu R, Snider AJ, Schrandt J, Li Y, Bialkowska AB, Li M, Zhou J, Hannun YA and Obeid LM et al.. (2016) Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system. Cell Death Dis 7: e2124 [PMID:26938296]
41. Xu R, Jin J, Hu W, Sun W, Bielawski J, Szulc Z, Taha T, Obeid LM and Mao C. (2006) Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P. FASEB J 20: 1813-25 [PMID:16940153]
42. Yang K, Nong K, Gu Q, Dong J and Wang J. (2018) Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model. Eur J Med Chem 151: 389-400 [PMID:29649738]
43. Yang K, Yu J, Nong K, Wang Y, Niu A, Chen W, Dong J and Wang J. (2020) Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant Activity. J Med Chem 63: 961-974 [PMID:31944697]
44. Yokomatsu T, Murano T, Akiyama T, Koizumi J, Shibuya S, Tsuji Y, Soeda S and Shimeno H. (2003) Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity. Bioorg Med Chem Lett 13: 229-36 [PMID:12482429]
45. Young SA, Mina JG, Denny PW and Smith TK. (2012) Sphingolipid and ceramide homeostasis: potential therapeutic targets. Biochem Res Int 2012: 248135 [PMID:22400113]